NYSE:RCUS

Arcus Biosciences News Headlines

$31.30
+0.40 (+1.29 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$30.68
Now: $31.30
$32.04
50-Day Range
$28.06
MA: $33.45
$39.01
52-Week Range
$15.03
Now: $31.30
$42.36
Volume316,144 shs
Average Volume538,868 shs
Market Capitalization$2.22 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.26

Headlines

Arcus Biosciences (NYSE RCUS) News Headlines Today

SourceHeadline
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual MeetingArcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting
finance.yahoo.com - April 10 at 9:05 AM
Arcus Biosciences (NYSE:RCUS) Trading Up 2.8%Arcus Biosciences (NYSE:RCUS) Trading Up 2.8%
americanbankingnews.com - April 9 at 11:44 AM
Why Arcus Biosciencess Stock is Up During Todays SessionWhy Arcus Biosciences's Stock is Up During Today's Session
msn.com - April 5 at 1:16 PM
Zacks: Analysts Anticipate Arcus Biosciences, Inc. (NYSE:RCUS) to Post -$0.71 EPSZacks: Analysts Anticipate Arcus Biosciences, Inc. (NYSE:RCUS) to Post -$0.71 EPS
americanbankingnews.com - April 4 at 4:18 AM
Independent Director Kathryn Falberg Just Bought 12% More Shares In Arcus Biosciences, Inc. (NYSE:RCUS)Independent Director Kathryn Falberg Just Bought 12% More Shares In Arcus Biosciences, Inc. (NYSE:RCUS)
finance.yahoo.com - April 3 at 11:25 AM
RCUS Makes Notable Cross Below Critical Moving AverageRCUS Makes Notable Cross Below Critical Moving Average
nasdaq.com - March 30 at 7:37 PM
Arcus Biosciences (NYSE:RCUS)  Shares Down 8.3% Arcus Biosciences (NYSE:RCUS) Shares Down 8.3%
americanbankingnews.com - March 29 at 2:37 PM
Precision BioSciences to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease DayPrecision BioSciences to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Day
finance.yahoo.com - March 29 at 7:43 AM
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business UpdatePrecision BioSciences Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 18 at 9:38 AM
Arcus Biosciences (NYSE:RCUS) Trading Up 5.5%Arcus Biosciences (NYSE:RCUS) Trading Up 5.5%
americanbankingnews.com - March 17 at 7:38 PM
Arcus Biosciences, Inc. (RCUS) Stock Jumps 9.5%: Will It Continue to Soar?Arcus Biosciences, Inc. (RCUS) Stock Jumps 9.5%: Will It Continue to Soar?
finance.yahoo.com - March 12 at 5:58 PM
Industry Analysts Just Upgraded Their Arcus Biosciences, Inc. (NYSE:RCUS) Revenue Forecasts By 10%Industry Analysts Just Upgraded Their Arcus Biosciences, Inc. (NYSE:RCUS) Revenue Forecasts By 10%
finance.yahoo.com - March 4 at 8:03 AM
Analysts Are Upgrading Arcus Biosciences, Inc. (NYSE:RCUS) After Its Latest ResultsAnalysts Are Upgrading Arcus Biosciences, Inc. (NYSE:RCUS) After Its Latest Results
finance.yahoo.com - February 28 at 11:24 AM
Arcus Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Operational HighlightsArcus Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Highlights
finance.yahoo.com - February 24 at 8:17 PM
Precision Bios ARCUS Gene Editing Platform Is Safe, Durable; Long-Term Animal Study ShowsPrecision Bio's ARCUS Gene Editing Platform Is Safe, Durable; Long-Term Animal Study Shows
markets.businessinsider.com - February 19 at 10:12 AM
Arcus Biosciences to Participate in Upcoming Investor ConferencesArcus Biosciences to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 11 at 7:51 PM
Have Insiders Been Buying Arcus Biosciences, Inc. (NYSE:RCUS) Shares This Year?Have Insiders Been Buying Arcus Biosciences, Inc. (NYSE:RCUS) Shares This Year?
finance.yahoo.com - February 10 at 1:33 PM
Fecal microbe transplants help cancer patients respond to immunotherapy and shrink tumorsFecal microbe transplants help cancer patients respond to immunotherapy and shrink tumors
msn.com - February 5 at 10:06 AM
Precision BioSciences to Present at Guggenheim Healthcare Talks 2021 Oncology DayPrecision BioSciences to Present at Guggenheim Healthcare Talks 2021 Oncology Day
markets.businessinsider.com - February 4 at 8:27 AM
Gilead Sciences to Increase Its Ownership In Arcus BiosciencesGilead Sciences to Increase Its Ownership In Arcus Biosciences
finance.yahoo.com - February 1 at 8:17 AM
Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic CancerArcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer
businesswire.com - January 15 at 1:15 PM
Affimed (AFMD) Catches Eye: Stock Jumps 8.8%Affimed (AFMD) Catches Eye: Stock Jumps 8.8%
finance.yahoo.com - January 14 at 3:57 PM
Arcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI SymposiumArcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI Symposium
finance.yahoo.com - January 11 at 5:17 PM
Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and CompanyPrecision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
benzinga.com - January 7 at 8:58 AM
Arcus Biosciences Appoints Biotech Industry Veteran, Andrew Perlman, M.D., Ph.D. and Gilead’s SVP of Research Biology, Michael Quigley, Ph.D. to Its Board of DirectorsArcus Biosciences Appoints Biotech Industry Veteran, Andrew Perlman, M.D., Ph.D. and Gilead’s SVP of Research Biology, Michael Quigley, Ph.D. to Its Board of Directors
finance.yahoo.com - January 6 at 5:56 PM
Are Options Traders Betting on a Big Move in Arcus Biosciences (RCUS) Stock?Are Options Traders Betting on a Big Move in Arcus Biosciences (RCUS) Stock?
finance.yahoo.com - January 4 at 11:54 AM
RCUS Jan 2021 25.000 callRCUS Jan 2021 25.000 call
au.finance.yahoo.com - December 26 at 2:09 AM
RCUS Jan 2021 12.500 putRCUS Jan 2021 12.500 put
au.finance.yahoo.com - December 26 at 2:09 AM
RCUS Jan 2021 30.000 putRCUS Jan 2021 30.000 put
au.finance.yahoo.com - December 25 at 9:09 PM
Arcus Biosciences Inc Registered Shs BuyArcus Biosciences Inc Registered Shs Buy
markets.businessinsider.com - November 25 at 10:31 PM
Arcus Biosciencesto Participate in the Evercore ISI 3rd Annual HealthCONx Virtual ConferenceArcus Biosciencesto Participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference
marketwatch.com - November 19 at 2:12 PM
Arcus Biosciences to Participate in the Evercore ISI 3rd Annual HealthCONx Virtual ConferenceArcus Biosciences to Participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference
finance.yahoo.com - November 18 at 6:30 PM
Analysts Just Published A Bright New Outlook For Arcus Biosciences, Inc.s (NYSE:RCUS)Analysts Just Published A Bright New Outlook For Arcus Biosciences, Inc.'s (NYSE:RCUS)
finance.yahoo.com - November 12 at 10:05 AM
Arcus Biosciences EPS beats by $0.62, beats on revenueArcus Biosciences EPS beats by $0.62, beats on revenue
seekingalpha.com - November 5 at 5:40 PM
Arcus Biosciences Announces Third Quarter 2020 Financial Results and Corporate UpdatesArcus Biosciences Announces Third Quarter 2020 Financial Results and Corporate Updates
finance.yahoo.com - November 5 at 5:40 PM
10 cancer deals later, Gilead says drug pipeline much stronger10 cancer deals later, Gilead says drug pipeline 'much stronger'
bizjournals.com - October 29 at 6:13 PM
Arcus to Collaborate With AstraZeneca on Registrational Trial for Domvanalimab, Arcus’s Novel Anti-TIGIT Antibody, Plus Imfinzi® in Stage III NSCLCArcus to Collaborate With AstraZeneca on Registrational Trial for Domvanalimab, Arcus’s Novel Anti-TIGIT Antibody, Plus Imfinzi® in Stage III NSCLC
finance.yahoo.com - October 29 at 7:26 AM
Arcus Biosciences (NYSE:RCUS) Shareholders Have Enjoyed An Impressive 119% Share Price GainArcus Biosciences (NYSE:RCUS) Shareholders Have Enjoyed An Impressive 119% Share Price Gain
finance.yahoo.com - October 20 at 1:54 PM
Jennifer Jarrett returns to Arcus Biosciences as COOJennifer Jarrett returns to Arcus Biosciences as COO
seekingalpha.com - October 2 at 8:49 AM
Hedge Funds Keep Buying Arcus Biosciences, Inc. (RCUS)Hedge Funds Keep Buying Arcus Biosciences, Inc. (RCUS)
finance.yahoo.com - September 28 at 5:16 PM
Precision Bio expands collaboration with Servier in cancerPrecision Bio expands collaboration with Servier in cancer
seekingalpha.com - September 17 at 9:47 AM
Arcus BiosciencesArcus Biosciences
benzinga.com - September 13 at 7:04 PM
Arcus Biosciences Inc (RCUS) CFO Ii Robert C. Goeltz Bought $107,850 of SharesArcus Biosciences Inc (RCUS) CFO Ii Robert C. Goeltz Bought $107,850 of Shares
finance.yahoo.com - September 10 at 10:32 AM
The Experience Design Studio Dramatically Expands Employee and Customer Base in 2020The Experience Design Studio Dramatically Expands Employee and Customer Base in 2020
finance.yahoo.com - September 9 at 10:09 AM
Public company in Durham earns key designation for leukemia treatmentPublic company in Durham earns key designation for leukemia treatment
bizjournals.com - August 19 at 5:37 PM
Trade Alert: The Co-Founder Of Arcus Biosciences, Inc. (NYSE:RCUS), Terry Rosen, Has Just Spent US$999k Buying 1.0% More SharesTrade Alert: The Co-Founder Of Arcus Biosciences, Inc. (NYSE:RCUS), Terry Rosen, Has Just Spent US$999k Buying 1.0% More Shares
finance.yahoo.com - August 17 at 1:44 PM
Arcus Biosciences Inc Registered Shs OutperformArcus Biosciences Inc Registered Shs Outperform
markets.businessinsider.com - August 12 at 7:16 PM
Arcus Biosciences EPS misses by $0.34, beats on revenueArcus Biosciences EPS misses by $0.34, beats on revenue
seekingalpha.com - August 6 at 8:28 PM
Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate UpdatesArcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates
finance.yahoo.com - August 6 at 8:28 PM
Arcus Biosciences Announces New Employment Inducement GrantArcus Biosciences Announces New Employment Inducement Grant
finance.yahoo.com - August 4 at 6:19 PM
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.